Liquid Biopsy Market Size is expected to develop at a compound annual growth rate (CAGR) of 24.5% from 2025 to 2035
The liquid biopsy market was estimated to be worth USD 6.1 billion globally in 2024, and a compound annual growth rate (CAGR) of 24.5% is anticipated throughout the course of the projected period. The market for liquid biopsies is expanding due to the growing number of non-invasive procedures and the increased incidence and prevalence of cancer. The market is expanding significantly due to rising demand for disease monitoring and growing public awareness of the treatment of chronic illnesses. A liquid biopsy is easier to use and more convenient than a standard biopsy. It encompasses many technologies, like circulating tumor DNA analysis and circulating tumor cells. The market is expanding as a result of less invasive testing, early cancer detection, and individualized medication. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/liquid-biopsy-market Growth Drivers The demand in the liquid biopsy market is being driven by th...